Medical Effectiveness and High-cost Drugs

Led by Anar Dossa who brings a wealth of expertise in drug cost management, and Jenni Noble, who brings her extensive experience of provider network management and end-to-end care strategy, this network tackles the evolving landscape of healthcare provision and costs, and the role of health insurance executives in shaping a sustainable way forward towards accessible, equitable and affordable healthcare. Topics such as care settings, effective deployment of digital technology, health technology assessment, personalised therapies, high-cost drugs, outcomes, reimbursement models, benchmarking around drug pricing, hospital stay duration, etc. all make this one of the core networks at iFHP. Network members include CEOs, CMOs, Heads of Provider Networks, Directors of Pharmacy, Heads of Strategy amongst others.
Anar Adossa

The group meets once a quarter online, each time in two separate sessions to allow all time zones access to the live network learnings and discussions. An in-person meeting is planned for March 2024, in New York.

Next virtual meeting dates:
6 Feb 2024 (2 meetings to cover all global time zones) and
7 May 2024 (2 meetings to cover all global time zones)

Next Meetings
Past meetings
Member Networks